Ti. Merkulova et al., C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction, FEBS LETTER, 443(1), 1999, pp. 41-47
At the termination step of protein synthesis, hydrolysis of the peptidyl-tR
NA is jointly catalysed at the ribosome by the termination codon and the po
lypeptide release factor (eRF1 in eukaryotes), eRF1 forms in vivo and in vi
tro a stable complex with release factor eRF3, an eRF1-dependent and riboso
me-dependent GTPase. The role of the eRF1(.)eRF3 complex in translation rem
ains unclear. We have undertaken a systematic analysis of the interactions
between the human eRF1 and eRF3 employing a yeast two-hybrid assay. We show
that the N-terminal parts of eRF1 (positions 1-280) and of eRF3 (positions
1-477) are either not involved or non-essential for binding. Two regions i
n each factor are critical for mutual binding: positions 478-530 and 628-63
7 of eRF3 and positions 281-305 and 411-415 of eRF1. The GTP binding domain
of eRF3 is not involved in complex formation with eRF1. The GILRY pentamer
(positions 411-415) conserved in eukaryotes and archaebacteria is critical
for eRF1's ability to stimulate eRF3 GTPase. The human eRF1 lacking 22 C-t
erminal amino acids remains active as a release factor and promotes an eRF3
GTPase activity whereas C-terminally truncated eRF3 is inactive as a GTPas
e. (C) 1999 Federation of European Biochemical Societies.